Moderate to Severe Atopic Dermatitis: Targeted Pathways and Strategies to Personalize Patient Care

Gain expert insights on personalizing care for patients with moderate to severe AD including choosing among current treatment options understanding emerging therapies and recommending vaccinations for patients receiving immunosuppressants and immunomodulatory therapies for AD.

Share

Program Content

No activities added yet

Activities

AD Treatment
Navigating the Biologic Treatment Landscape for Atopic Dermatitis: The Pharmacist’s Role
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2022

Expires: May 31, 2023

Faculty

cover img faculity

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES

Associate Professor of Pharmacy Practice
Duquesne University Mylan School of Pharmacy
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Incyte Corporation